Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junru Liu

Showing results (31-40 of 124) with videos related to

Pageof 13
Sort By:
Oncotarget|August 25, 2016
Application of PET/CT in treatment response evaluation and recurrence prediction in patients with newly-diagnosed multiple myelomaYing Li, Junru Liu, Beihui Huang, et al.
Journal of Cancer Research and Clinical Oncology|May 9, 2021
Clinical value of minimal residual disease assessed by multiparameter flow cytometry in amyloid light chain amyloidosisXiaozhe Li, Beihui Huang, Junru Liu, et al.
Cancer Medicine|May 10, 2026
Outcomes Among MM Patients Receiving Early Intervention for MRD Progression Following Autologous Stem Cell TransplantationXiaozhe Li, Meilan Chen, Lifen Kuang, et al.
Analytical Chemistry|December 3, 2024
Targeted Conversion from Mitochondria to the Nucleus of Hydroxystyrylpyridinium by Introducing Only an Additional <i>o</i>-Hydroxyl GroupShuai Yan, Tao Xie, Junru Liu, et al.
Archives of Endocrinology and Metabolism|March 19, 2021
Inverse association of plasma hydrogen sulfide levels with visceral fat area among Chinese young men: a cross-sectional studyDongmei Fan, Huiyan Huang, Xing Wang, et al.
Acta Biochimica Et Biophysica Sinica|May 22, 2013
Everolimus enhances the cytotoxicity of bendamustine in multiple myeloma cells through a network of pro-apoptotic and cell-cycle-progression regulatory proteinsBo Lu, Juan Li, Jingxuan Pan, et al.
Frontiers in Oncology|February 6, 2023
Development and validation of a chemotherapy tolerance prediction model for Chinese multiple myeloma patients: The TM frailty scoreYadong Chen, Jingli Gu, Beihui Huang, et al.
Medicine|July 11, 2026
The risk of rash for cancer patients treated with PD-1/PD-L1 inhibitors: An updated systematic review and meta-analysisQunqun Jiang, Junru Liu, Zhuoqi Li, et al.
Computational and Mathematical Methods in Medicine|January 10, 2022
MicroRNA-603 Promotes Progression of Cutaneous Melanoma by Regulating TBX5Xianghua Dong, Ying Wang, Yan Qu, et al.
Leukemia & Lymphoma|August 10, 2011
High prevalence of hepatitis B virus infection in multiple myelomaBeihui Huang, Juan Li, Zhenhai Zhou, et al.
Pageof 13

Showing results (31-40 of 124) with videos related to

Sort By:
Pageof 13
Oncotarget|August 25, 2016
Application of PET/CT in treatment response evaluation and recurrence prediction in patients with newly-diagnosed multiple myelomaYing Li, Junru Liu, Beihui Huang, et al.
Journal of Cancer Research and Clinical Oncology|May 9, 2021
Clinical value of minimal residual disease assessed by multiparameter flow cytometry in amyloid light chain amyloidosisXiaozhe Li, Beihui Huang, Junru Liu, et al.
Cancer Medicine|May 10, 2026
Outcomes Among MM Patients Receiving Early Intervention for MRD Progression Following Autologous Stem Cell TransplantationXiaozhe Li, Meilan Chen, Lifen Kuang, et al.
Analytical Chemistry|December 3, 2024
Targeted Conversion from Mitochondria to the Nucleus of Hydroxystyrylpyridinium by Introducing Only an Additional <i>o</i>-Hydroxyl GroupShuai Yan, Tao Xie, Junru Liu, et al.
Archives of Endocrinology and Metabolism|March 19, 2021
Inverse association of plasma hydrogen sulfide levels with visceral fat area among Chinese young men: a cross-sectional studyDongmei Fan, Huiyan Huang, Xing Wang, et al.
Acta Biochimica Et Biophysica Sinica|May 22, 2013
Everolimus enhances the cytotoxicity of bendamustine in multiple myeloma cells through a network of pro-apoptotic and cell-cycle-progression regulatory proteinsBo Lu, Juan Li, Jingxuan Pan, et al.
Frontiers in Oncology|February 6, 2023
Development and validation of a chemotherapy tolerance prediction model for Chinese multiple myeloma patients: The TM frailty scoreYadong Chen, Jingli Gu, Beihui Huang, et al.
Medicine|July 11, 2026
The risk of rash for cancer patients treated with PD-1/PD-L1 inhibitors: An updated systematic review and meta-analysisQunqun Jiang, Junru Liu, Zhuoqi Li, et al.
Computational and Mathematical Methods in Medicine|January 10, 2022
MicroRNA-603 Promotes Progression of Cutaneous Melanoma by Regulating TBX5Xianghua Dong, Ying Wang, Yan Qu, et al.
Leukemia & Lymphoma|August 10, 2011
High prevalence of hepatitis B virus infection in multiple myelomaBeihui Huang, Juan Li, Zhenhai Zhou, et al.
Pageof 13